NCT00267592 2016-05-19Safety and Efficacy of Talampanel in Glioblastoma MultiformeTeva Branded Pharmaceutical Products R&D, Inc.Phase 2 Completed72 enrolled
NCT00062504 2011-05-23Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTeva Branded Pharmaceutical Products R&D, Inc.Phase 2 Terminated30 enrolled